|
|
|
||||
|
|
|||||
|
Computerized results of Menopause Type® Questionnaire: |
|||||
|
Menopause Type® Four |
See Pages
101-111 |
||||
|
Menopause Type®
Four has symptoms that reveal decreased
estrogen function with normal progesterone & testosterone function.
Health risks associated with Menopause
Type® Four may include
osteoporosis and heart disease, as well as memory problems. Since estradiol
plays an important role in blood glucose metabolism, there is also increased risk
of insulin resistance and blood sugar disorders. Risks associated with
insulin resistance include increased risk of heart disease, diabetes and
endometrial cancer. |
|||||
|
PROTOCOL: The following protocol provides women with
Menopause Type® 4 information on which nutritional and herbal
formulations can support the normal function of hormone responsive tissues.
Please review the Advanced
Integrative Management of Menopause document for more
detailed information. |
|||||
|
Foundational Interventions: |
|||||
|
Foundational interventions include lifestyle and dietary choices that support optimal hormone function. In addition, a high grade multiple vitamin mineral formulation rich in antioxidants and essential fatty acids rich in docosahexaenoic acid are required for optimal hormone function. |
|||||
|
Ultra Preventive® X V-Cap - A high grade multiple
vitamin and mineral supplement with significant antioxidant support. Vitamins
and minerals are cofactors required
for every biochemical process in the human body, including the production and
proper detoxification of hormones. Oxygen stress contributes to some of the
pathophysiolgical effects of suboptimal menopause. These effects may be
prevented and/or treated by improving the antioxidant defense of
perimenopause, menopause, and postmenopausal women. |
|||||
|
Opti DHA - An essential fatty acid
rich in docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), with a
high DHA:EPA ratio. The essential fatty acid DHA help maintain ideal cell membrane
fluidity allowing optimal transport of molecules across the membrane, which
is critical for hormone function, while EPA helps the body control
inflammation. |
|||||
|
Primary Endocrine Formulations : |
|||||
|
Primary
Endocrine Nutraceutical formulations should be used to support the function
of hormone producing glands and hormone responsive tissues. The primary formulation that is
appropriate to manage hormonal imbalances observed in Menopause Type® Four include: |
|||||
|
Estro-Mend™ is a
unique blend of isoflavones, phytoestrogens and other herbs to naturally
support hormonal balance by supporting
the ideal function of estrogen responsive tissues as needed in Menopause Type®
Four. More Information Estro-Mend™ |
|||||
|
Please Find a Healthcare Professional in your area to customize these
protocols. |
|||||
|
Secondary Endocrine Formulations: |
|||||
|
Since
decreased thyroid function can adversely
affect the function of other hormones, a nutraceutical formulation to support the function of the
thyroid gland and the liver (which converts T4 to T3)
and also supports the function and response of tissues that respond to
thyroid hormones should be used if there are signs and symptoms of decreased thyroid function. As noted, there may be decreased blood glucose function in Menopause Type®
Four due to the primary hormone imbalances. Excessive body weight also
increases the risk for decreased blood
glucose function. A nutraceutical
formulation to support healthy blood glucose function should be used if there
are signs and symptoms of decreased
blood sugar function |
|||||
|
Thyro-Mend™ is a synergistic
combination of iodine containing seaweeds, and herbs which contain phytothyroidogenic,
phyto-thyroid-receptor agonists, and other herbs designed to promote optimal
function of thyroid hormones by maintaining the health of thyroid hormone
producing tissues and by supporting the healthy function of tissues that
respond to thyroid hormones. More information on Thyro-Mend™. |
|||||
|
Glucobrium
is a synergistic formulation of phytotherapeutic extracts which mimic and
potentiate the actions of insulin and support healthy blood glucose function.
More information on Glucobrium. |
|||||
|
When
to Consider Hormone Precursors & Bioidentical Hormone Replacement Therapy |
|||||
|
Hormone precursors such as Pregnenolone 25 Mg Tab and DHEA 5 MG may be used to support hormone production pathways that create
estrogens. They have mild hormone actions in and of themselves, and do not
have the same risks that are associated with Hormone Replacement Therapies
(HRT). Bioidentical Hormone Replacement Therapy (BHRT),
while considered more appropriate than synthetic hormone therapies, does not
support the hormone production pathways, but instead provides “replacement”,
which may further diminish endogenous hormone production. Evaluation of hormone levels, use of hormone
precursors as needed, and as a final
course of action, the prescription of bioidentical hormone therapies
should be considered only when restoration of normal function is not
possible. |
|||||
|
Also Review: |
|||||
|
Make the Right Choice |
|||||
|
Work with a Healthcare Professional
in your area: Find a healthcare professional in your area who has shown
such commitment as to take an extensive course of study on menopause type®
management, including nutritional, herbal & natural hormone therapies. Please go to Find a Healthcare Professional . |
|||||
|
How Your Menopause
Type® Was Calculated
(www.YourMenopauseType.com/Questionnaire.html#Calculate) |
|||||
|
|
|||||
|
♦These statements have not been evaluated by the
Food and Drug Administration. |
|||||
|
Review Disclaimer & Legal
(www.YourMenopauseType.com/Disclaimer) |
|||||
YourMenopauseType.com,
Inc.
|
|||||
|
Last
update03/18/07 |
|||||
|
|
|||||